Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chymotrypsin-like activity of beta 5 (β5) subunit (Leishmania donovani) (β5 subunit)
- Target
- β5 subunit
- Molecular classification
- Enzyme, Protease, Proteasome subunit
01
Overview
The chymotrypsin-like activity of the β5 subunit is a proteolytic function within the 20S proteasome complex of *Leishmania donovani*. It is essential for regulated protein degradation, maintaining cellular homeostasis by removing damaged or unneeded proteins. Inhibition of this activity is a validated drug target.
- Other names
- Leishmania donovani beta 5 subunitL. donovani β5 subunit chymotrypsin-like activityProteasome β5 subunit (L. donovani)
02
Mechanism of action
Inhibition of chymotrypsin-like activity of the β5 subunit in the Leishmania donovani proteasome, leading to disruption of protein turnover and parasite death.
03
Biological functions
Protein degradationProtein homeostasisRegulated proteolysis
04
Disease associations
InfectionVisceral Leishmaniasis
05
Safety considerations
Potential for off-target effects on human proteasomeDevelopment of drug resistance through mutations (e.g., G197S)Selectivity for parasite vs. human proteasome required
06
Interacting drugs
Selective β5 subunit inhibitors
Beyond the preview
Go deeper on Chymotrypsin-like activity of beta 5 (β5) subunit (Leishmania donovani) (β5 subunit).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chymotrypsin-like activity of beta 5 (β5) subunit (Leishmania donovani) (β5 subunit).